Colonoscopy — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Colonoscopy is an endoscopic examination of the entire large bowel (colon and rectum) using a flexible, lighted camera (colonoscope) approximately 160 cm long and 13 mm in diameter, inserted through the rectum and advanced to the caecum (and often the terminal ileum). It serves dual diagnostic and therapeutic functions: identifying and characterising mucosal pathology (cancer, polyps, inflammation, vascular lesions), taking targeted biopsies, and performing therapeutic interventions including polypectomy, haemostasis, stricture dilation, and stent placement. Colonoscopy is performed by gastroenterologists, colorectal surgeons, and trained endoscopists in accredited endoscopy units. It is considered the gold standard investigation for the colon, with a diagnostic yield superior to CT colonography for polyps under 6 mm and the unique advantage of allowing simultaneous therapy. Population-based colorectal cancer screening programmes using colonoscopy reduce colorectal cancer incidence by 70–90% through detection and removal of adenomatous polyps before malignant transformation. Approximately 15 million colonoscopies are performed annually in the USA. Colonoscopy is performed by gastroenterologists, colorectal surgeons, and trained endoscopic nurses in accredited endoscopy units. Over 700,000 colonoscopies are performed annually in England through the NHS Bowel Cancer Screening Programme, making it one of the most commonly performed endoscopic procedures. Modern high-definition colonoscopes with narrow-band imaging (NBI) enhance adenoma detection rates.

Colonoscopy is indicated for a broad range of clinical presentations and preventive indications. Screening colonoscopy is recommended from age 45 in average-risk individuals (US Preventive Services Task Force, 2021) or age 50 in lower-risk populations (NICE UK guidelines). Higher-risk groups requiring earlier or more frequent surveillance include first-degree relatives of colorectal cancer patients (begin at 40 or 10 years before the index case, whichever is earlier), patients with inflammatory bowel disease (IBD — Crohn's colitis or ulcerative colitis) beginning surveillance at 8–10 years of disease duration, and hereditary syndromes (Lynch syndrome, familial adenomatous polyposis). Symptomatic indications include: rectal bleeding (haematochezia or haemoccult-positive stool), change in bowel habit (new persistent diarrhoea or constipation), unexplained iron-deficiency anaemia, abdominal pain with red flag features, unexplained weight loss, and abnormal CT findings suggesting colonic pathology. Surveillance colonoscopy intervals after adenoma removal depend on polyp characteristics per British Society of Gastroenterology (BSG) 2020 and American Gastroenterological Association (AGA) 2020 guidelines.

Colonoscopy requires thorough bowel preparation the day before the procedure: a clear liquid diet and a prescribed bowel laxative solution (polyethylene glycol 2–4 litres, sodium picosulfate, or sodium phosphate preparation) to evacuate all faecal material. On the day, the patient is cannulated for IV access and receives sedation — typically midazolam 2–5 mg plus fentanyl 50–100 mcg (conscious sedation) or propofol (deep sedation) — alongside a pharyngeal lubricant and positioning in the left lateral decubitus position. The colonoscope is introduced through the rectum and systematically advanced through each colonic segment (sigmoid, descending, splenic flexure, transverse, hepatic flexure, ascending, caecum) guided by torque, loop reduction manoeuvres, and patient repositioning. Air, CO2, or water insufflation distends the lumen for visualisation. CO2 is preferred as it is absorbed faster, reducing post-procedure bloating. The examination is performed during withdrawal (minimum 6 minutes withdrawal time is a quality indicator). Polyps are removed by snare polypectomy (cold snare for polyps under 10 mm, hot snare polypectomy for larger lesions) or endoscopic mucosal resection (EMR) for flat or sessile lesions over 2 cm. Haemostatic clips or injection are applied if bleeding occurs. Water-exchange colonoscopy — infusing and suctioning water rather than air to distend the colon during insertion — reduces procedural pain and improves adenoma detection rates compared to air insufflation. Carbon dioxide (CO2) is preferred over room air for colonic distension as it is absorbed 150 times faster, reducing post-procedural bloating and discomfort.

Colonoscopy with polypectomy provides definitive prevention of colorectal cancer by removing adenomatous polyps before they undergo malignant transformation — a process that takes 5–10 years in the adenoma-carcinoma sequence. Population-level data from the National Polyp Study demonstrated a 76–90% reduction in colorectal cancer incidence in patients who underwent colonoscopy with polypectomy compared to historical controls. Early-stage colorectal cancer detected by screening colonoscopy (stage I) has a 5-year survival rate of 90–92%, compared to 14% for stage IV disease. Colonoscopy simultaneously diagnoses and treats multiple conditions in a single session — no second procedure is required for polypectomy or haemostasis. It provides diagnostic certainty superior to any other non-invasive investigation. From a medical tourism standpoint, colonoscopy in India costs approximately INR 5,000–15,000 (USD 60–180), compared to USD 2,000–4,000 in the USA or GBP 1,500–3,000 in the UK. The procedure is outpatient, allowing same-day discharge.

Colonoscopy is a very safe procedure when performed by trained endoscopists in accredited units. Perforation — the most serious complication — occurs in approximately 0.03–0.1% of diagnostic colonoscopies and 0.1–0.5% of therapeutic (polypectomy) procedures. Risk is higher with large or flat polyp EMR. Perforation usually requires surgical repair (laparoscopic or open). Post-polypectomy bleeding occurs in 0.3–2% of patients, particularly after large polyp removal; most episodes are managed endoscopically (clips or injection). Delayed bleeding can occur up to 14 days post-polypectomy and requires urgent colonoscopy. Adverse reactions to IV sedation including respiratory depression occur in under 0.5% and are managed by trained nursing and anaesthetic support. Post-polypectomy electrocoagulation syndrome — a localised peritoneal inflammation causing fever and abdominal pain after polypectomy — occurs in under 1% and usually resolves with conservative management. The adenoma miss rate (proportion of adenomas present but not detected) is 6–12% for small adenomas in quality endoscopy units; quality indicators including adenoma detection rate (ADR) over 25% in men and 20% in women are mandated quality benchmarks.

Patients recover in the day unit for 1–2 hours until the sedation has fully resolved and observations are stable. Bloating and cramping from insufflated air or CO2 resolve within a few hours (faster with CO2). Mild rectal discomfort is normal. Patients must not drive, operate machinery, or sign legal documents for 24 hours following IV sedation — a responsible adult must accompany them home. Normal diet and activities resume the same day once sedation has cleared. If a large polyp was removed, a soft diet for 24 hours and avoidance of NSAIDs and anticoagulants for 7 days reduces delayed bleeding risk. Results from biopsies and polyp histology return within 5–10 working days and are discussed at a follow-up appointment or by letter/phone call. Future colonoscopy surveillance intervals are determined by polyp characteristics: no polyps — 10 years; 1–4 tubular adenomas under 10 mm — 5 years (UK) or 7 years (USA); 5–10 adenomas or any adenoma over 10 mm — 3 years; serrated polyposis — 1–3 years. Patients are advised to contact the endoscopy unit if they develop fever, severe abdominal pain, or significant rectal bleeding following the procedure.